A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

NCT05689099 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Healthy Participants

Interventions

DRUG: Semaglutide B, 1.34 mg/mL
DRUG: Semaglutide B, 0.68 mg/mL

Sponsor

Novo Nordisk A/S